© 2024 WRVO Public Media
NPR News for Central New York
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

Cat And Dog Take Supreme Court Arguments In Stride

Yes, that's really a cat on a leash in the crowd outside the Supreme Court Monday.
Jessica Marcy
/
Kaiser Health News
Yes, that's really a cat on a leash in the crowd outside the Supreme Court Monday.

No circus would be complete without a few animals.

So wouldn't you know the big crowd outside the U.S. Supreme Court today included a cat on a leash and an adorable chihuahua mix with health insurance.

Kaiser Health News' Jessica Marcy snapped the shot of the cat, stretched out on the steps leading to the courthouse, as she was rushing to cover the arrival of Republican presidential candidate Rick Santorum.

He swung by to say that he, rather than Mitt Romney, is the right guy to do away with the administration's overhaul law.

Marcy told me she didn't have time to get the name of the cat or its owner.

But Neda Semnani, who writes the Heard on the Hill column for Roll Call, told me the cat is 13 years old and named "Pud," short for pudding.

She says cat and owner regularly walk around Washington when the weather is nice. "It was an unpolitical move," she says of their stroll today. She'll have more about them in Tuesday's paper. (Update: Here's Semnani's item.)

And then there's Ellie, a miniature dachshund and chihuahua mix. She came with Katherine Prather, a first year medical student at Georgetown University.

"I brought her because she has health insurance, and she thinks everyone should have health insurance," said Prather, of Kansas City, Mo.

Pets aren't covered by the health overhaul. But maybe they should be. The cost of health insurance for pets has surged, averaging $650 a year according to a recent report.

For more picture of the scene outside the court, see Marcy's gallery at Kaiser Health News.

Copyright 2021 NPR. To see more, visit https://www.npr.org.

Scott Hensley edits stories about health, biomedical research and pharmaceuticals for NPR's Science desk. During the COVID-19 pandemic, he has led the desk's reporting on the development of vaccines against the coronavirus.